Drug Trial Radar · NCT02159729
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Last checked: Nov 19, 2026Latest source record: Feb 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
205
Actual
Start
Feb 2009
Primary completion
Dec 2015
Study completion Dec 2015
Sponsor
- Lead sponsor
- Kythera BiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jun 10, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Other
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This was a long-term follow-up study of participants who completed Kythera-sponsored trials of ATX-101 (06-03, 07-07, 09-15)
Conditions
- Submental Fat
- Healthy
Interventions
PlaceboDrug
Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements and recording adverse events
ATX-101 (1 mg/cm^2)Drug
Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements and recording adverse events
ATX-101 (2 mg/cm^2)Drug
Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements and recording adverse events
ATX-101 (4 mg/cm^2)Drug
Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements and recording adverse events
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Maintaining CR-SMFRS 1-Grade Response During 5 Years of Follow up, i.e. % of Participants Who Were CR-SMFRS 1-Grade Responders at Both Long-term LTFU Baseline and at Subsequent LTFU VisitsTime frame: Up to 60 months from long-term follow-up (LTFU) baseline (the last visit in the previous study)
- Percentage of Participants Maintaining PR-SMFRS 1-Grade Response During 5 Years of Follow up, i.e. % of Participants Who Were PR-SMFRS 1-Grade Responders at Both Long-term LTFU Baseline and at Subsequent LTFU VisitsTime frame: Up to 60 months from long-term follow-up (LTFU) baseline (the last visit in the previous study)
- Percentage of Participants Maintaining Composite SMFRS 1-Grade Response During 5 Years of Follow up, i.e. % of Participants Who Were CR-SMFRS and PR-SMFRS 1-Grade Responders at Both Long-term LTFU Baseline and at Subsequent LTFU VisitsTime frame: Up to 60 months from long-term follow-up (LTFU) baseline (the last visit in the previous study)
- Percentage of Participants Maintaining Composite SMFRS 2-Grade Response During 5 Years of Follow up, i.e. % of Participants Who Were CR-SMFRS and PR-SMFRS 2-Grade Responders at Both Long-term LTFU Baseline and at Subsequent LTFU VisitsTime frame: Up to 60 months from long-term follow-up (LTFU) baseline (the last visit in the previous study)
Locations
20 sites in 4 countries. Site status is shown where the registry gives one.
Total Skin & Beauty Dermatology Center
Birmingham, Alabama
Clinical Testing Center Beverly Hills
Beverly Hills, California
Mokusiga, Inc
Beverly Hills, California
Plastic & Reconstructive Surgery
San Francisco, California
Dermatology Institute of DuPage Medical Group in Naperville
Naperville, Illinois
Skin Care Physicians
Chestnut Hill, Massachusetts
Minnesota Clinical Study Center
Fridley, Minnesota
Body Aesthetic Research Center
St Louis, Missouri
Skin Specialists, PC
Omaha, Nebraska
Research Across America
Plano, Texas
Mei-Heng Tan
Sydney, New South Wales, Australia
Skin Centre, AHC House
Benowa, Queensland, Australia
Southeast Dermatology Belmont Specialist Centre
Carina Heights, Queensland, Australia
T/AS Dermatology Institute of Victoria
South Yarra, Victoria, Australia
Niagara Falls Dermatology & Skin Care
Niagara Falls, Ontario, Canada
Institute of Cosmetic & Laser Surgery
Oakville, Ontario, Canada
Toronto Cosmetic Skin Surgery Centre
Toronto, Ontario, Canada
Cosmetic Dermatology on Bloor
Toronto, Ontario, Canada
Cranley Clinic, Harcout House
London, United Kingdom
The Dermatology Centre
Salford, Manchester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.